.png){kind=icon}
.png){kind=icon}
Return
Higher cardiovascular risk observed with beta-blockers in CKD patients without prior cardiovascular disease
.png){kind=icon}
OA
AI
S
M
J
S
DOI：10.1093/ckj/sfag204.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Chronic kidney disease (CKD) is strongly linked to cardiovascular disease (CVD) risk. Although beta-blockers (BBs) are widely used for CVD prevention, their effectiveness and safety in CKD patients without established CVD remain uncertain.
Journal
IF:
4.6
Papers:
2.9K
Citations:
7.1K
Organization
Cited Papers